Alwin Scharstuhl Selected Research

Leukemia

1/2015

Cell-type-specific downregulation of heme oxygenase-1 by lipopolysaccharide via Bach1 in primary human mononuclear cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alwin Scharstuhl Research Topics

Disease

2	Wounds and Injuries (Trauma) 12/2014 - 12/2007
2	Osteoarthritis 12/2003 - 07/2002
2	Osteophyte 12/2003 - 07/2002
1	Systemic Scleroderma (Systemic Sclerosis) 11/2016
1	Inflammation (Inflammations) 11/2016
1	Leukemia 01/2015
1	Malaria 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Sepsis (Septicemia) 01/2013
1	Renal Insufficiency (Renal Failure) 01/2013
1	Cicatrix (Scar) 12/2010
1	Hypertrophic Cicatrix (Hypertrophic Scar) 08/2009
1	Synovitis 12/2003

Drug/Important Bio-Agent (IBA)

3	Heme (Haem)IBA 11/2016 - 12/2010
2	EnzymesIBA 11/2016 - 01/2015
2	Heme Oxygenase-1IBA 11/2016 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 12/2014 - 01/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2003 - 07/2002
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2016
1	CXC ChemokinesIBA 12/2014
1	CollagenIBA 12/2014
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 12/2010
1	CurcuminIBA 08/2009
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2003
1	PapainIBA 12/2003
1	Proteoglycans (Proteoglycan)IBA 12/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2002

Therapy/Procedure

1	Hip Replacement Arthroplasty (Total Hip Replacement) 12/2007